Class II · ModerateRecall completed
Semaglutide/Cyanocobalamin 5/2 MG/ML Injectable
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLots: 08122022@8 BUD: 09/11/2022; 08162022@3 BUD: 09/15/2022
Where it was soldNationwide in the USA.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Lack of Assurance of Sterility
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Carolina Infusion |
Show the full FDA record
| Full product label | Semaglutide/Cyanocobalamin 5/2 MG/ML Injectable, 0.2 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936. |
| Recalling firm | Carolina Infusion |
| Distribution | Nationwide in the USA. |
| Quantity | 24 syringes |
| Recall initiated | 2022-08-26 |
| Report date | 2022-09-21 |
| Recall completed | — |
| Recall number | D-1519-2022 |
| Classification | Class II |
| FDA status | Completed |
| Origin on file | Ridgeland SC United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.